Sharon Osbourne showed off her very plump pout as she attended her husband Ozzy Osbourne's 'Working Class Hero' exhibition at ...

CALL 0905 789 0404* 24 July-23 Aug You’re about regain your voice, as messenger Mercury enters your sign and a New Moon in ...

The I-Team scrambles, a journalist makes a strange trip to Mexico, a bombshell report airs, and Casey turns to public ridicule and defiance ...

The Member of Parliament (MP) for Walewale in the North East Region, Dr. Mahama Tia Abdul Kabiru, has announced an ambitious plan to set up a state-of-the-art recording studio aimed at nurturing ...

Elon Musk issued a curt rebuke of ketamine abuse allegations after a viral clip of his erratic behavior at a dinner recirculated online. The clip—taken in March during a visit to President ...

POLICE have been given more time to quiz a man arrested after 79 people were injured when a car ploughed into crowds in Liverpool. Footage shows the moment a man was hauled out of the car after it … ...

Below, I've offered an early preview of the trade deadline. You'll find sections highlighting the three most interesting buyers, sellers, and bubble teams, as well as a breakdown of 10 notable trade ...

Peptide-drug conjugates (PDCs) are emerging as a promising alternative to antibody-drug conjugates (ADCs), offering enhanced tumor penetration and reduced immunogenicity. Carbonic anhydrase IX (CAIX) ...

DeepSeek—No. 1 on our list of the most innovative companies in Asia-Pacific—trained state-of-the-art models at far lower cost and with far less GPU power than anyone thought possible.

Azealia Banks continues to wage war against rising rap star and newfound rival Doechii, with Banks accusing her of using cocaine in response to her viral freestyle. On Sunday (Jan. 5), Azealia ...

Google Docs is getting a Gemini AI-powered image generator sidebar that makes clip art-style images using the Imagen 3 model. It’s only for paid users, though. Skip to main content.

AbbVie said Monday that its experimental treatment for schizophrenia failed to significantly help patients in two trials, a blow to the company, which got the drug through its recent $9 billion ...